CCCC
Price
$2.32
Change
+$0.14 (+6.42%)
Updated
Jul 18 closing price
Capitalization
164.74M
17 days until earnings call
IDYA
Price
$21.59
Change
-$0.50 (-2.26%)
Updated
Jul 18 closing price
Capitalization
1.89B
23 days until earnings call
Interact to see
Advertisement

CCCC vs IDYA

Header iconCCCC vs IDYA Comparison
Open Charts CCCC vs IDYABanner chart's image
C4 Therapeutics
Price$2.32
Change+$0.14 (+6.42%)
Volume$3.96M
Capitalization164.74M
IDEAYA Biosciences
Price$21.59
Change-$0.50 (-2.26%)
Volume$549.68K
Capitalization1.89B
CCCC vs IDYA Comparison Chart in %
Loading...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CCCC vs. IDYA commentary
Jul 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CCCC is a Hold and IDYA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 20, 2025
Stock price -- (CCCC: $2.32 vs. IDYA: $21.59)
Brand notoriety: CCCC and IDYA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CCCC: 279% vs. IDYA: 50%
Market capitalization -- CCCC: $164.74M vs. IDYA: $1.89B
CCCC [@Biotechnology] is valued at $164.74M. IDYA’s [@Biotechnology] market capitalization is $1.89B. The market cap for tickers in the [@Biotechnology] industry ranges from $293.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CCCC’s FA Score shows that 1 FA rating(s) are green whileIDYA’s FA Score has 0 green FA rating(s).

  • CCCC’s FA Score: 1 green, 4 red.
  • IDYA’s FA Score: 0 green, 5 red.
According to our system of comparison, CCCC is a better buy in the long-term than IDYA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CCCC’s TA Score shows that 6 TA indicator(s) are bullish while IDYA’s TA Score has 2 bullish TA indicator(s).

  • CCCC’s TA Score: 6 bullish, 4 bearish.
  • IDYA’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, CCCC is a better buy in the short-term than IDYA.

Price Growth

CCCC (@Biotechnology) experienced а +4.04% price change this week, while IDYA (@Biotechnology) price change was -3.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.68%. For the same industry, the average monthly price growth was +13.07%, and the average quarterly price growth was +34.43%.

Reported Earning Dates

CCCC is expected to report earnings on Aug 06, 2025.

IDYA is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+2.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDYA($1.89B) has a higher market cap than CCCC($165M). IDYA YTD gains are higher at: -15.992 vs. CCCC (-35.556). CCCC has higher annual earnings (EBITDA): -102.74M vs. IDYA (-356.46M). IDYA has more cash in the bank: 693M vs. CCCC (215M). IDYA has less debt than CCCC: IDYA (26M) vs CCCC (64.4M). CCCC has higher revenues than IDYA: CCCC (39.8M) vs IDYA (7M).
CCCCIDYACCCC / IDYA
Capitalization165M1.89B9%
EBITDA-102.74M-356.46M29%
Gain YTD-35.556-15.992222%
P/E RatioN/AN/A-
Revenue39.8M7M569%
Total Cash215M693M31%
Total Debt64.4M26M248%
FUNDAMENTALS RATINGS
IDYA: Fundamental Ratings
IDYA
OUTLOOK RATING
1..100
58
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
80
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CCCCIDYA
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 6 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
76%
Momentum
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
81%
MACD
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
71%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
83%
Advances
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 12 days ago
77%
Declines
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 3 days ago
77%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
69%
Aroon
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TCBPY0.380.04
+11.57%
TC BioPharm (Holdings) plc
OTGLF74.10N/A
N/A
CD Projekt SA
RWWI14.70N/A
N/A
Rand Worldwide, Inc.
XLMDF0.05N/A
N/A
XLMEDIA PLC
NISTF18.70-0.25
-1.32%
Nippon Steel Corporation

CCCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CCCC has been loosely correlated with CRBU. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if CCCC jumps, then CRBU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CCCC
1D Price
Change %
CCCC100%
+6.42%
CRBU - CCCC
54%
Loosely correlated
+12.02%
KYMR - CCCC
53%
Loosely correlated
-0.37%
BEAM - CCCC
53%
Loosely correlated
+1.47%
FATE - CCCC
51%
Loosely correlated
-1.74%
IDYA - CCCC
51%
Loosely correlated
-2.26%
More

IDYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with CGON. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then CGON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDYA
1D Price
Change %
IDYA100%
-2.26%
CGON - IDYA
61%
Loosely correlated
N/A
IMNM - IDYA
61%
Loosely correlated
+1.24%
DNLI - IDYA
60%
Loosely correlated
-3.65%
NRIX - IDYA
59%
Loosely correlated
-7.28%
XENE - IDYA
59%
Loosely correlated
N/A
More